关于德克斯梅德托米丁作为一种最佳疗法,用于紧急腹部手术的老年人出现痴呆症的治疗
Hong-Su Zhou1,2, Yue Gu1, Yi-Huan Guan2
1Department of Anesthesia West China Hospital, Sichuan University Chengdu China.
Ibrain
|October 3, 2023
概括
老年患者出现妄 (ED) 是麻醉后护理单位 (PACU) 的一个挑战. 这项案例研究强调了德克斯梅德托米丁作为一种成功的ED救援疗法,即使是器官功能障碍.
科学领域:
- 麻醉学 麻醉学
- 老年医学 老年医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 出现妄想 (ED) 是老年患者经常出现的麻醉后并发症.
- 对于老年人的ED,特别是那些有重要器官功能障碍的人,目前还没有专门的治疗方法.
- 接受紧急腹部手术和患有血管心脏病的老年患者面临更高的ED风险.
研究的目的:
- 审查文献并分析老年患者患有特定并发症的ED风险因素.
- 确认德克斯梅托米丁作为在麻醉后护理单位 (PACU) 治疗ED的救援疗法的有效性和验证.
- 为了突出一个成功的ED治疗用德克斯梅德托米丁治疗的案例.
主要方法:
- 文献综述侧重于老年人ED的危险因素.
- 一个涉及ED的老年患者的案例研究的分析.
- 在PACU环境中使用德克斯梅德托米丁的药理学审查.
主要成果:
- 德克斯梅德托米丁证明了成功治疗老年患者的出现妄想症.
- 该研究确定了在该患者群体中导致ED的潜在风险因素.
- 已注意到关于在PACU中使用德克斯梅德托米丁的有限文献.
结论:
- 德克斯梅德托米丁 (Dexmedetomidine) 是一种有效的救援疗法,可用于PACU中老年患者出现痴呆症的治疗.
- 需要进一步研究更大的样本大小来验证这些发现.
- 识别和管理风险因素对于预防易受伤害的老年患者的ED至关重要.
更多相关视频
07:54Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
19.8K
06:59A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
30.5K
相关概念视频
Parenteral Anesthetics: Overview
151
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
151
Stages of General Anesthesia
489
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
489
Skeletal Muscle Relaxants: Therapeutic Uses
506
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
506
Skeletal Muscle Relaxants: Adverse Effects
393
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
393
Depolarizing Blockers: Pharmocokinetics
347
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
347
Drugs for Treatment of Diarrhea-Predominant IBS
200
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
200
